Status:
TERMINATED
Time To Complications Occurs in Diabetes
Lead Sponsor:
Karolinska Institutet
Conditions:
Retinopathy
Nephropathy
Eligibility:
All Genders
18-99 years
Brief Summary
Diabetes causing serious complications is well known. In this study the aim is to follow 950 patients with diabetes for 15 years to study when, in who and how the diabetes complications occurs.
Detailed Description
Background: That diabetes cause serious diabetic complications from the eyes, kidneys, nerves and large vessels is known. Good metabolic control during the first 8-10 years has been shown to delay an...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diabetes type 1, 2 or LADA: 18-75 years of age.
- Group A: 150 Type 1 Diabetes, duration 15 years (+/-2 years) and 150 Type 2
- Diabetes 2 years (+/-2 years) (50% F/M)
- Group B: 150 Type 1 Diabetes, duration 20 years (+/-2 years) and 150 Type 2
- Diabetes 7 years (+/-2 years) (50% F/M)
- Group C: 150 Type 1 Diabetes, duration 25 years (+/-2 years) and 150 Type 2
- Diabetes 12 years (+/-2 years) (50% F/M)
- Group D: 50 LADA, onset after 35 years of age, duration of 5-10 years (50% F/M)
- Type 1 Diabetes: Positive ICA antibodies and/or GAD-antibodies and/or neg C-peptide. Debut \<30 years of age.
- Type 2 Diabetes: Negative ICA-antibodies and GAD-antibodies and pos C-peptide (\>0.35 mmol/l).
- LADA: Positive ICA-antibodies and/or GAD-antibodies. Debut \>35 years of age.
Exclusion
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00969956
Start Date
April 1 2012
End Date
February 1 2018
Last Update
August 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Molecular Medicine and Surgery, Rolf Luft Research centre for Diabetes and Endocrinology
Stockholm, Sweden, 171 76